Haemonetics (NYSE:HAE) Price Target Raised to $86.00

Дата публикации: 10-08-2026 05:36:49

Haemonetics (NYSE:HAE – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $62.00 to $86.00 in a research note issued to investors on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical instruments supplier’s stock. Several other brokerages also recently commented on HAE. Raymond James […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
2	HA Sustainable Infrastructure Capital (NYSE:HASI) Price Target Raised to $51.00	0	13.77	10-08-2026
3	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
4	Genpact (NYSE:G) Price Target Raised to $45.00	0	14.26	10-08-2026
5	Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00	0	12.25	10-08-2026
6	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
7	Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00	0	13.82	10-08-2026
8	MKS (NASDAQ:MKSI) Price Target Raised to $380.00	0	13.85	10-08-2026
9	Halozyme Therapeutics (NASDAQ:HALO) Price Target Raised to $115.00	0	11.48	10-08-2026
10	Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00	0	14.22	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.69. Источник: www.americanbankingnews.com.